Opava, Czechia

Tomas Andrysek

This inventor holds 2 USPTO granted patents. Top assignee: Galena as. Active years: 2000-2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tomas Andrysek. Retrieved from https://idiyas.com/inventor/tomas-andrysek

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.5

ph-index = 2

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 2000-2002

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Tomas Andrysek

Introduction

Tomas Andrysek is a notable inventor based in Opava, Czech Republic. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compositions. With a total of 2 patents, his work has garnered attention in the scientific community.

Latest Patents

Among his latest patents is an immunomodulatory pharmaceutical composition designed to form lyotropic liquid crystals when in contact with an aqueous phase. This formulation includes a Cyclosporin component, showcasing his expertise in pharmaceutical innovations.

Career Highlights

Tomas Andrysek is currently associated with Galena AS, where he continues to push the boundaries of pharmaceutical research. His work focuses on creating effective drug formulations that can improve patient outcomes.

Collaborations

He has collaborated with notable colleagues such as Milan Stuchlik and Vladimir Matha, contributing to a dynamic research environment that fosters innovation.

Conclusion

Tomas Andrysek's contributions to pharmaceutical inventions highlight his role as a key innovator in the industry. His patents reflect a commitment to advancing medical science and improving therapeutic options.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…